U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Clinicians Connect: Conversations with FDA’s Chief Medical Officer on reducing the cases of congenital syphilis and syphilis - 12/04/2024
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
Clinicians Connect: Conversations with FDA’s Chief Medical Officer on reducing the cases of congenital syphilis and syphilis
December 4, 2024

Title: Clinicians Connect: Conversations with FDA’s Chief Medical Officer on reducing the cases of congenital syphilis and syphilis 

Date: December 4, 2024, 1-2 P.M. ET 

Overview: Clinicians will hear directly from the FDA, CDC, HHS, and NIH about what we can do to address the recent surge in syphilis and its impact on individuals, pregnant people and babies. 

Presenters include:

  • Hilary Marston, M.D., M.P.H., Chief Medical Officer, Office of the Commissioner, FDA
  • Kaye Hayes, M.P.A., Deputy Assistant Secretary for Infectious Disease and Director, Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, HHS
  • Susan Bersoff-Matcha, M.D., Deputy Director, Office of Women’s Health, Office of the Commissioner, FDA
  • Bradley Stoner, M.D., Ph.D., Director, Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC
  • Carolyn D. Deal, Ph.D., Chief, Enteric and Sexually Transmitted Infections Branch, National Institute of Allergy and Infectious Disease, NIH
Back to Top